眼动脱敏与再加工治疗对比支持性治疗预防有创伤史双相障碍患者情感复发:随机对照试验研究方案
本研究为单盲、随机对照、多中心试验,拟纳入82例有创伤史的双相障碍患者,随机分配至眼动脱敏与再加工(EMDR)治疗组或支持性治疗组,两组均接受20次心理治疗、每次60分钟、为期6个月。主要结局为12个月和24个月后情感发作的减少,预期EMDR组更优。
要点
- 有创伤史的双相障碍患者可达60%,与发作更严重、共病风险更高和复发率更高相关。
- EMDR组与支持性治疗组均接受20次心理治疗,每次60分钟,为期6个月。
- 主要结局为12个月和24个月后情感发作减少,预期EMDR组更优。
核心结论
- 本研究结果将提供证据,判断针对双相障碍患者的特定EMDR方案是否能有效减少情感发作、情感症状以及功能、认知和创伤症状。
研究设计与样本
- 单盲、随机对照、多中心试验,拟招募82例有创伤事件史的双相障碍患者,随机分配至EMDR治疗组或支持性治疗组。
主要发现
- 原文为研究方案,未报告研究结果。
关键数值与推荐
- 两组患者均接受20次心理治疗,每次60分钟,为期6个月。
- 主要结局为12个月和24个月后情感发作的减少,预期EMDR组更优。
- 次要结局包括EMDR组情感症状更大程度减少,采用双相抑郁评定量表、杨氏躁狂评定量表和修改用于双相障碍的临床总体印象量表测量。
- 次要结局包括EMDR组认知状态、社会认知和功能表现更好,分别采用精神病认知障碍筛查、Mayer-Salovey-Caruso情绪智力测验和功能评估短测验测量。
- 创伤事件采用Holmes-Rahe生活应激量表、临床医生用PTSD量表和事件影响量表评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 60% of patients with bipolar disorder (BD) have a history of traumatic events, which is associated with greater episode severity, higher risk of comorbidity and higher relapse rates. Trauma-focused treatment strategies for BD are thus necessary but studies are currently scarce. The aim of this study is to examine whether Eye Movement Desensitization and Reprocessing (EMDR) therapy focusing on adherence, insight, de-idealisation of manic symptoms, prodromal symptoms and mood stabilization can reduce episode severity and relapse rates and increase cognitive performance and functioning in patients with BD. METHODS/DESIGN: This is a single-blind, randomized controlled, multicentre trial in which 82 patients with BD and a history of traumatic events will be recruited and randomly allocated to one of two treatment arms: EMDR therapy or supportive therapy. Patients in both groups will receive 20 psychotherapeutic sessions, 60 min each, during 6 months. The primary outcome is a reduction of affective episodes after 12 and 24 months in favour of the EMDR group. As secondary outcome we postulate a greater reduction in affective symptoms in the EMDR group (as measured by the Bipolar Depression Rating Scale, the Young Mania Rating Scale and the Clinical Global Impression Scale modified for BD), and a better performance in cognitive state, social cognition and functioning (as measured by the Screen for Cognitive Impairment in Psychiatry, The Mayer-Salovey-Caruso Emotional Intelligence Test and the Functioning Assessment Short Test, respectively). Traumatic events will be evaluated by The Holmes-Rahe Life Stress Inventory, the Clinician-administered PTSD Scale and the Impact of Event Scale. DISCUSSION: The results of this study will provide evidence whether a specific EMDR protocol for patients with BD is effective in reducing affective episodes, affective symptoms and functional, cognitive and trauma symptoms. TRIAL REGISTRATION: The trial is registered at ClinicalTrials.gov, identifier: NCT02634372 . Registered on 3 December 2015.
引用
- Moreno-Alcázar A, Radua J, Landín-Romero R, et al. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28376919. doi:10.1186/s13063-017-1910-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。